5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway
Background: Our previous study found that 5-Aza-2′-deoxycytidine (5-Aza-CdR) can repress the expression and activity of protein serine/threonine phosphatase-1γ (PP1γ) in mouse hippocampus. It is well known that PP1γ regulates cell metabolism, which is related to hypoxia/ischaemia tolerance. It has b...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-10-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332219319250 |
id |
doaj-0c8ef8726cd24c4d971ad6dbd3ac1be4 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ruifang Qi Xiaolu Zhang Yabin Xie Shuyuan Jiang You Liu Xiaolei Liu Wei Xie Xiaoe Jia Rengui Bade Ruili Shi Sijie Li Changhong Ren Kerui Gong Chunyang Zhang Guo Shao |
spellingShingle |
Ruifang Qi Xiaolu Zhang Yabin Xie Shuyuan Jiang You Liu Xiaolei Liu Wei Xie Xiaoe Jia Rengui Bade Ruili Shi Sijie Li Changhong Ren Kerui Gong Chunyang Zhang Guo Shao 5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway Biomedicine & Pharmacotherapy Autophagy 5-Aza-2′-deoxycytidine Hypoxia tolerance TSC1 |
author_facet |
Ruifang Qi Xiaolu Zhang Yabin Xie Shuyuan Jiang You Liu Xiaolei Liu Wei Xie Xiaoe Jia Rengui Bade Ruili Shi Sijie Li Changhong Ren Kerui Gong Chunyang Zhang Guo Shao |
author_sort |
Ruifang Qi |
title |
5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway |
title_short |
5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway |
title_full |
5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway |
title_fullStr |
5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway |
title_full_unstemmed |
5-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway |
title_sort |
5-aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the tsc1/mtor pathway |
publisher |
Elsevier |
series |
Biomedicine & Pharmacotherapy |
issn |
0753-3322 |
publishDate |
2019-10-01 |
description |
Background: Our previous study found that 5-Aza-2′-deoxycytidine (5-Aza-CdR) can repress the expression and activity of protein serine/threonine phosphatase-1γ (PP1γ) in mouse hippocampus. It is well known that PP1γ regulates cell metabolism, which is related to hypoxia/ischaemia tolerance. It has been reported that it can also induce autophagy in cancer cells. Autophagy is important for maintaining cellular homeostasis associated with metabolism. In this study, we examined whether 5-Aza-CdR increases hypoxia tolerance-dependent autophagy by initiating the TSC1/mTOR/autophagy signalling pathway in neuronal cells. Methods: 5-Aza-CdR was either administered to mice via intracerebroventricular injection (i.c.v) or added to cultured hippocampal-derived neuronal cell line (HT22 cell) in the medium for cell culture. The hypoxia tolerance of mice was measured by hypoxia tolerance time and Perl's iron stain. The mRNA and protein expression levels of tuberous sclerosis complex 1 (TSC1), mammalian target of rapamycin (mTOR) and autophagy marker light chain 3 (LC3) were measured by real-time PCR and western blot. The p-mTOR and p-p70S6k proteins were used as markers for mTOR activity. In addition, the role of autophagy was determined by correlating its intensity with hypoxia tolerance in a time-dependent manner. At the same time, the involvement of the TSC1/mTOR pathway in autophagy was also examined through transfection with TSC1 (hamartin) plasmid. Results: 5-Aza-CdR was revealed to increase hypoxia tolerance and induce autophagy, accompanied by an increase in mRNA and protein expression levels of TSC1, reduction in p-mTOR (Ser2448) and p-p70S6k (Thr389) protein levels, and an increase in the ratio of LC3-II/LC3-I in both mouse hippocampus and hippocampal-derived neuronal cell line (HT22). The fluorescence intensity of hamartin was enhanced in the hippocampus of mice exposed to 5-Aza-CdR. Moreover, HT22 cells that over-expressed TSC1 showed more autophagy. Conclusions: 5-Aza-CdR can increase hypoxia tolerance by inducing autophagy by initiating the TSC1/mTOR pathway. |
topic |
Autophagy 5-Aza-2′-deoxycytidine Hypoxia tolerance TSC1 |
url |
http://www.sciencedirect.com/science/article/pii/S0753332219319250 |
work_keys_str_mv |
AT ruifangqi 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT xiaoluzhang 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT yabinxie 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT shuyuanjiang 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT youliu 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT xiaoleiliu 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT weixie 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT xiaoejia 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT renguibade 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT ruilishi 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT sijieli 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT changhongren 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT keruigong 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT chunyangzhang 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway AT guoshao 5aza2deoxycytidineincreaseshypoxiatolerancedependentautophagyinmouseneuronalcellsbyinitiatingthetsc1mtorpathway |
_version_ |
1721432943340027904 |
spelling |
doaj-0c8ef8726cd24c4d971ad6dbd3ac1be42021-05-21T04:17:33ZengElsevierBiomedicine & Pharmacotherapy0753-33222019-10-011185-Aza-2′-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathwayRuifang Qi0Xiaolu Zhang1Yabin Xie2Shuyuan Jiang3You Liu4Xiaolei Liu5Wei Xie6Xiaoe Jia7Rengui Bade8Ruili Shi9Sijie Li10Changhong Ren11Kerui Gong12Chunyang Zhang13Guo Shao14Department of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, School of Basic Medical Science, Capital Medical University, Beijing, China; Inner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaInner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaBeijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaBeijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, ChinaDepartment of Oral and Maxillofacial Surgery, University of California San Francisco, San Francisco, USADepartment of neurosurgery, the First Affiliated Hospital of Baotou Medical College, Inner Mongolia, ChinaDepartment of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, School of Basic Medical Science, Capital Medical University, Beijing, China; Inner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing key laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China; Corresponding author at: Department of Neurobiology and Center of Stroke, Beijing Institute for Brain Disorders, School of Basic Medical Science, Capital Medical University, Beijing, China.Background: Our previous study found that 5-Aza-2′-deoxycytidine (5-Aza-CdR) can repress the expression and activity of protein serine/threonine phosphatase-1γ (PP1γ) in mouse hippocampus. It is well known that PP1γ regulates cell metabolism, which is related to hypoxia/ischaemia tolerance. It has been reported that it can also induce autophagy in cancer cells. Autophagy is important for maintaining cellular homeostasis associated with metabolism. In this study, we examined whether 5-Aza-CdR increases hypoxia tolerance-dependent autophagy by initiating the TSC1/mTOR/autophagy signalling pathway in neuronal cells. Methods: 5-Aza-CdR was either administered to mice via intracerebroventricular injection (i.c.v) or added to cultured hippocampal-derived neuronal cell line (HT22 cell) in the medium for cell culture. The hypoxia tolerance of mice was measured by hypoxia tolerance time and Perl's iron stain. The mRNA and protein expression levels of tuberous sclerosis complex 1 (TSC1), mammalian target of rapamycin (mTOR) and autophagy marker light chain 3 (LC3) were measured by real-time PCR and western blot. The p-mTOR and p-p70S6k proteins were used as markers for mTOR activity. In addition, the role of autophagy was determined by correlating its intensity with hypoxia tolerance in a time-dependent manner. At the same time, the involvement of the TSC1/mTOR pathway in autophagy was also examined through transfection with TSC1 (hamartin) plasmid. Results: 5-Aza-CdR was revealed to increase hypoxia tolerance and induce autophagy, accompanied by an increase in mRNA and protein expression levels of TSC1, reduction in p-mTOR (Ser2448) and p-p70S6k (Thr389) protein levels, and an increase in the ratio of LC3-II/LC3-I in both mouse hippocampus and hippocampal-derived neuronal cell line (HT22). The fluorescence intensity of hamartin was enhanced in the hippocampus of mice exposed to 5-Aza-CdR. Moreover, HT22 cells that over-expressed TSC1 showed more autophagy. Conclusions: 5-Aza-CdR can increase hypoxia tolerance by inducing autophagy by initiating the TSC1/mTOR pathway.http://www.sciencedirect.com/science/article/pii/S0753332219319250Autophagy5-Aza-2′-deoxycytidineHypoxia toleranceTSC1 |